treated MRIdian, the Today, we to answering And thanks update discuss everyone. QX forward making joining and questions. look will on the progress we Michaella. review across we’re call. an and Good organization, our then our you, afternoon, your Thank results begin with with financials patients for
our customers past leading dozens notice. increasingly are is customers and I’ve we clinical the understood provide that the with opportunity engage of the to globe. capabilities Over had quarter, across It taking
patients, and market personalized clearly are physicians, providers, seeking. We Our direction our provide with in noninvasive, line payers is trends. constituents, medicine that
systems around Broad compelling globally. grade critical outcomes over now of treated toxicity to therapy to grow. patients MRIdian clinical XX zero Our have driving three is and the or evidence continues our utilization world higher of with X,XXX adoption
we’re to As MRIdian we in the speak, new Kingdom. bringing a geography patients United
will site we high Our for deliver preparations and and our are first the UK Customers term system well SBRT gated system. be in are are beam near underway up to second and looking positioned. exceptionally running safely dose
similarities like can our While strike see, the one and tries to the offering, draw no to shape tumor competition MRIdian.
Our recent Texas. premier programs MRIdian referred example radiation treatment. institution for in differentiation. demonstrates in a the patient one His receiving A been of in the academic capabilities at grounded Miami to our oncologist our of had patient treatment
been institution in In list. capacity in another of centers. patients fact, sites. have waiting MRIdian at demand interest our treatment catchment several are notice at major increasing area. Patients referred midwestern to There one this a also this driving MRIdian four-week is is This leading taking
fractions adaptive XX the in of first multiple They and day conducted treatments than a have northeast customer impressively, Also, on beyond. conducted merits MRIdian in educating activated They’re more adaptive the on newly one. patients month. their
our full for prepare belt, work share path to have we As our now four under we foundational done quarters have let the me ahead.
care. and newness in functions this dedicated to important vault we’re pipelines. service, our paradigm ago team innovation our would areas to new Several pursuing our our readiness, studies highlight drive year in exist of across clinical these the is increased recognize didn’t clinical training or team enhanced. functional as up either We all such progress field have I significantly initiatives been and Concurrently, a have team. customer investment we our of clinical in of have the It commercial, built areas.
We are this therapy. early the next making of commercializing in progress company generation we’re stages while the across
heard our desire and to They times listened have customers simplified We clearly. for and dose high workflow faster adaptive SBRT. treatment
directly are efforts responsive. Our
and software faster MLC new launching are year. next early a We
reducing XXXX; additions standalone. on we’ll in timeframe, times with therapy. continue parody treatment We These another to critical SBRT beam anticipate high and standard that XX-minute this will path adaptive dose significantly will put our gated capability believe advances We a set will later upgrade from us sub on treatments. auto yet launch enhanced treatment of
in three on units. million the Moving $XX.X upgrades. driven primarily including Revenue We three revenue quarter was eight in QX to results. by took QX orders
$XXX to our the During approximately grew quarter, million. backlog
we capable the that projects have ability and As last to PO call, quarter’s mentioned patient on drive a highly for stages in below permitting months. advanced of we to planning, are first have built down XX treated our operations team customer
We this have successfully multiple in achieved instances.
as long-term customer extend We can process instances, our pace which have delays also is this experienced we we’re is for this when at relationships. believe In as advanced, right customer’s preparation not moving simply significantly. these
We that want set have also are the they well. may elongated capability build variability to out here new and latest we our cancer timeframes although the orders centers, The of received customers building see as we punchline, we multiple nature view technology, have from business. this as the now
Turning to cash.
as in approximately was was $XX quarter. Our cash million anticipated. the utilization This
The the investors is create right believe optionality. we company, capitalization path of and line are of the listened we to on have worked investors. carefully interest best hard we in to Regarding the with
to not directly the also further yet guarantee As details a will company. that we of long-term reiterate we with investors are in as place, the goals are the that not cannot in and on I share will we working line outcome. is agreements responsive definitive solution
our over turn now will Michaella the QX to financials. I to discuss call